European Commission
Public Health
Accessibility tools
Service tools
Language selector
- Current languageen
Navigation path
Community Register of medicinal products
Community register of veterinary medicinal products |
AUTHORISED |
Product information |
| Invented name: | Pexion
|
| Auth. number : | EU/2/12/147 |
| INN : | Imepitoin |
| ATC: | QN - Nervous system QN03 - Antiepileptics QN03A - Antiepileptics QN03AX - Other antiepileptics QN03AX90 - Imepitoin (See WHO ATCvet Index) |
| Indication: | For the reduction of the frequency of generalised seizures due to idiopathic epilepsy in dogs for use after careful evaluation of alternative treatment options |
| Marketing Authorisation Holder: | Boehringer Ingelheim Vetmedica GmbH
D-55216 Ingelheim am Rhein, Deutschland |
EPAR and active package presentations
Package presentations
|
The section of the Community Register "Package presentations" will no longer be updated as from 2 November 2012.
Information about presentations can be found in the website of the European Medicines Agency under the section "Product Information". Likewise, presentations on which there has been a Commission decision are referred in the Summary of Product Characteristics (Annex I to the Commission Decision granting the marketing authorisation) which continues to be available in the Community Register. |
European Commission procedures
| Close date procedure | Procedure type | EMEA number | Decision | summary publ | decision docs | annex |
| 27/02/2013 | Centralised - Authorisation | EMEA/V/C/2543 | (2013)1187 of 25/02/2013 |